Literature DB >> 19833090

Analysis of drug interactions with high-density lipoprotein by high-performance affinity chromatography.

Sike Chen1, Matthew R Sobansky, David S Hage.   

Abstract

Columns containing immobilized lipoproteins were prepared for the analysis of drug interactions with these particles by high-performance affinity chromatography (HPAC). This approach was evaluated by using it to examine the binding of high-density lipoprotein (HDL) to the drugs propranolol and verapamil. HDL was immobilized by the Schiff base method onto silica and gave HPAC columns with reproducible binding to propranolol over 4-5days of continuous operation at pH 7.4. Frontal analysis experiments indicated that two types of interaction were occurring between R- or S-propranolol and HDL at 37 degrees C: saturable binding with an association equilibrium constant (K(a)) of 1.1-1.9x10(5)M(-1) and nonsaturable binding with an overall affinity constant (n K(a)) of 3.7-4.1x10(4)M(-1). Similar results were found at 4 and 27 degrees C. Verapamil also gave similar behavior, with a K(a) of 6.0x10(4) M(-1) at 37 degrees C for the saturable sites and an n K(a) for the nonsaturable sites of 2.5x10(4)M(-1). These measured affinities gave good agreement with solution phase values. The results indicated that HPAC can be used to study drug interactions with HDL, providing information that should be valuable in obtaining a better description of how drugs are transported within the body. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19833090      PMCID: PMC2808466          DOI: 10.1016/j.ab.2009.10.017

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  25 in total

Review 1.  High-performance affinity chromatography: a powerful tool for studying serum protein binding.

Authors:  David S Hage
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2002-02-25       Impact factor: 3.205

2.  Evaluation of the human serum albumin column as a discovery screening tool for plasma protein binding.

Authors:  Lisa Buchholz; Chun-Hua Cai; Larry Andress; Adriaan Cleton; Joanne Brodfuehrer; Lucinda Cohen
Journal:  Eur J Pharm Sci       Date:  2002-03       Impact factor: 4.384

3.  Binding analysis of nilvadipine to plasma lipoproteins by capillary electrophoresis-frontal analysis.

Authors:  N A Mohamed; Y Kuroda; A Shibukawa; T Nakagawa; S El Gizawy; H F Askal; M E El Kommos
Journal:  J Pharm Biomed Anal       Date:  1999-12       Impact factor: 3.935

4.  Frontal analysis of drug-plasma lipoprotein binding using capillary electrophoresis.

Authors:  Takanori Ohnishi; Niveen Abdel Latif Mohamed; Akimasa Shibukawa; Yukihiro Kuroda; Terumichi Nakagawa; Samia El Gizawy; Hassan F Askal; Micheal E El Kommos
Journal:  J Pharm Biomed Anal       Date:  2002-01-15       Impact factor: 3.935

5.  Enzymatic determination of total serum cholesterol.

Authors:  C C Allain; L S Poon; C S Chan; W Richmond; P C Fu
Journal:  Clin Chem       Date:  1974-04       Impact factor: 8.327

6.  Preparation and properties of a cholesterol oxidase from Nocardia sp. and its application to the enzymatic assay of total cholesterol in serum.

Authors:  W Richmond
Journal:  Clin Chem       Date:  1973-12       Impact factor: 8.327

Review 7.  Free drug measurements: methodology and clinical significance.

Authors:  T C Kwong
Journal:  Clin Chim Acta       Date:  1985-10-15       Impact factor: 3.786

8.  The distribution of bound propranolol between the different human serum proteins.

Authors:  S Glasson; R Zini; P d'Athis; J P Tillement; J R Boissier
Journal:  Mol Pharmacol       Date:  1980-03       Impact factor: 4.436

Review 9.  Reversible and covalent binding of drugs to human serum albumin: methodological approaches and physiological relevance.

Authors:  Carlo Bertucci; Enrico Domenici
Journal:  Curr Med Chem       Date:  2002-08       Impact factor: 4.530

Review 10.  Characterization of drug-protein interactions in blood using high-performance affinity chromatography.

Authors:  David S Hage; Abby Jackson; Matthew R Sobansky; John E Schiel; Michelle J Yoo; K S Joseph
Journal:  J Sep Sci       Date:  2009-03       Impact factor: 3.645

View more
  16 in total

1.  Analysis of Drug Interactions with Lipoproteins by High-Performance Affinity Chromatography.

Authors:  Matthew R Sobansky; David S Hage
Journal:  Adv Med Biol       Date:  2012

Review 2.  Pharmaceutical and biomedical applications of affinity chromatography: recent trends and developments.

Authors:  David S Hage; Jeanethe A Anguizola; Cong Bi; Rong Li; Ryan Matsuda; Efthimia Papastavros; Erika Pfaunmiller; John Vargas; Xiwei Zheng
Journal:  J Pharm Biomed Anal       Date:  2012-01-14       Impact factor: 3.935

3.  Detection of heterogeneous drug-protein binding by frontal analysis and high-performance affinity chromatography.

Authors:  Zenghan Tong; K S Joseph; David S Hage
Journal:  J Chromatogr A       Date:  2011-05-06       Impact factor: 4.759

Review 4.  Analysis of stereoselective drug interactions with serum proteins by high-performance affinity chromatography: A historical perspective.

Authors:  Zhao Li; David S Hage
Journal:  J Pharm Biomed Anal       Date:  2017-01-11       Impact factor: 3.935

5.  Biointeraction analysis of carbamazepine binding to alpha1-acid glycoprotein by high-performance affinity chromatography.

Authors:  Hai Xuan; K S Joseph; Chunling Wa; David S Hage
Journal:  J Sep Sci       Date:  2010-08       Impact factor: 3.645

6.  Development of affinity microcolumns for drug-protein binding studies in personalized medicine: interactions of sulfonylurea drugs with in vivo glycated human serum albumin.

Authors:  Jeanethe Anguizola; K S Joseph; Omar S Barnaby; Ryan Matsuda; Guadalupe Alvarado; William Clarke; Ronald L Cerny; David S Hage
Journal:  Anal Chem       Date:  2013-04-17       Impact factor: 6.986

7.  Entrapment of alpha1-acid glycoprotein in high-performance affinity columns for drug-protein binding studies.

Authors:  Cong Bi; Abby Jackson; John Vargas-Badilla; Rong Li; Giana Rada; Jeanethe Anguizola; Erika Pfaunmiller; David S Hage
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2015-11-27       Impact factor: 3.205

Review 8.  Studies of metabolite-protein interactions: a review.

Authors:  Ryan Matsuda; Cong Bi; Jeanethe Anguizola; Matthew Sobansky; Elliott Rodriguez; John Vargas Badilla; Xiwei Zheng; Benjamin Hage; David S Hage
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2013-11-25       Impact factor: 3.205

Review 9.  Analysis of biomolecular interactions using affinity microcolumns: a review.

Authors:  Xiwei Zheng; Zhao Li; Sandya Beeram; Maria Podariu; Ryan Matsuda; Erika L Pfaunmiller; Christopher J White; NaTasha Carter; David S Hage
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2014-01-27       Impact factor: 3.205

10.  Analysis of drug interactions with very low density lipoprotein by high-performance affinity chromatography.

Authors:  Matthew R Sobansky; David S Hage
Journal:  Anal Bioanal Chem       Date:  2014-08-08       Impact factor: 4.142

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.